DOCSLIB.ORG

Review Article a Gene Map of Congenitalmalformations

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Review Article a Gene Map of Congenitalmalformations I Med Genet 1994;31:507-517 507 Review article J Med Genet: first published as 10.1136/jmg.31.7.507 on 1 July 1994. Downloaded from A gene map of congenital malformations Andrew 0 M Wilkie, Joanna S Amberger, Victor A McKusick Abstract process". The suggested distinction from dys- Congenital malformations frequently plasia ("an abnormal organisation of cells into arise sporadically, making it difficult to tissue(s) and its morphologic result(s)")'0 is determine whether or not they are gen- difficult to make in practice. Here we have etic in aetiology, let alone which gene(s) included macroscopically detectable, external may be involved. Nevertheless, rapid or intemal structural anomalies (including progress has been made over recent years dysmorphic facial features or growth retard- in the localisation and identification of ation), present at birth in a significant propor- gene mutations in specific malforma- tion ( > 5%) of cases, with a provisional (P) or tions. This review draws from Mendelian confirmed (C) localisation on the human gene inheritance in man Johns Hopkins map. Metabolic disorders with anomalies de- University Press, 11th ed, 1994) and the tectable at birth (for example, mucolipidosis online version (OMIM) to catalogue 139 type II, GM1 gangliosidosis, Bloom syn- loci (including 65 specifically identified drome) are thus included in the listing, but genes) implicated in congenital malfor- non-dysmorphic conditions or those develop- mations. Some of the most interesting ing during infancy are not. Other macroscopi- recent developments are discussed. cally detectable abnormalities such as congen- ital cataract, polycystic kidney disease, and (J7 Med Genet 1994;31:507-517) fetal hydrops as a result of homozygous a0 thalassaemia are included, but disorders that are subtle or only microscopically detectable Congenital anomalies contribute significantly to (for example, retinitis pigmentosa, juven- the burden of human disease; Baird et al' have ile nephronophthisis, spherocytosis) are estimated their birth incidence to be over 5%. excluded. Disorders of skin structure (for ex- http://jmg.bmj.com/ Their aetiology may be chromosomal, single ample, ichthyosis, hyperkeratosis, epidermo- gene, environmental, polygenic, multifactorial, lysis bullosa) are included, but those of pig- or unknown. The final three categories com- mentation (albinism, piebaldism) are not. prise the majority, and very few "polygenes" Most chromosomal localisations classified as have yet been implicated in congenital malfor- "in limbo" (L) have been excluded, but a few mations (the association of cleft lip ± palate cases in which the evidence appears relatively with genetic variation at the transforming strong are retained (preceded by a question on September 28, 2021 by guest. Protected copyright. growth factor-alpha locus in 2p13 is one excep- mark in table 2 and the figure). Some classic tion).2' However, considerable progress has dysmorphic syndromes (for example, Angel- been made in the identification of chromoso- man, fragile X) that are rarely associated with mal, single gene, and environmental contribu- congenital malformations and would be diffi- tions to malformation: this article summarises cult to diagnose at birth are included. current (March 1994) knowledge about those The list comprises 139 loci, including 65 disorders that have been mapped in the human specifically identified genes. In the great genome. Detailed information on each disorder majority of instances the affected infant is provided in table 1, arranged in chromosomal carries the mutation, but in a few cases (rhesus Institute of Molecular order: the nomenclature used has recently been haemolytic disease, maternal phenylketonuria, Medicine, John explained in this Journal.4 Table 2 presents an fetal hydantoin syndrome), the abnormality Radcliffe Hospital, Headington, Oxford alphabetical list of these disorders for ease of arises from maternal-fetal interaction (disrup- OX3 9DU, UK reference, and the figure shows their localisa- tion).10 Most identified genes encode enzymes A 0 M Wilkie tion on the human genome map. Appropriate or structural proteins, and have been isolated Center for Medical references may be found in McKusick's cata- using classical biochemical techniques (finc- Genetics, The Johns logue,5 together with various reviews.69 Cita- tional cloning). Notable recent progress has Hopkins University tions in this article are selective and refer to been made in elucidating the heterogeneous School of Medicine, recent or molecular 12 Blalock Building, particularly pertinent work. basis of Zellweger syndrome," Room 1007, 600 N In compiling this gene map we had some Fanconi anaemia,"3 and epidermolysis bullosa'4 Wolfe Street, difficulty in deciding which particular disorders by this approach. Although relatively few genes Baltimore, MD as "congenital malformations". have been identified by positional cloning,78 the 21287-4922, USA qualified et a as "a J S Amberger Spranger al'0 defined malformation number is accelerating rapidly. Strategies used V A McKusick morphologic defect of an organ, part of an have included a combination of genetic linkage organ, or larger region of the body resulting Correspondence to and gross chromosomalrearrangement (neuro- Dr Wilkie. from an intrinsically abnormal developmental fibromatosis type 1),chromosomal rearrange- 508 Wilkie, Amberger, McKusick c-C 1-1 0. C '. .0 .00. >1 C) o S. P U U n -S D4 :+ - _/ _S U, 00 N N - -_ -_ J Med Genet: first published as 10.1136/jmg.31.7.507 on 1 July 1994. Downloaded from C) _ _ 0 0 10'0>1 '-'0 (A C.- Q 0. C) .0li C> a C)4 co 0CG o(> C) 0 -C)00 Q co U 0 E . *0 N .N ° C) 0 0.bo 5~v C)Cu oaG e9z=00 0 oJo 00Cu0XW- C) :> 04,D Q 0~ ° Et. S_= o 0C 0Cu) C).beCq G 4L Cu lCC0.C) .00 0.0 g.4 g0. E, C) sO 0c 0 co '0 < <'0 '0 «< OW44 Q~44 Cu. (.0 4 X (Z 4, co C) 4i~^; vc ^.1 w c 0o4404uQQ(.o4Q u CuC . 44CU9 IX U U^M U UU i;c V4 oo0uro 0000000 0 0 0 000 00000ooooooo oooooo 0ooooo 0000 oC o0o00o n ao o ON- -ot0woooN0 o 0 - c- 0-o o o t- oo0 o n oroooouNo- un o 0o-o00 q0o N o t t a% a u, 0 U, c-C 0% Co Nc Il " c-C %C 00MO c-,-.,CU Co tU, u,0% _o oo_tt--unO,N %0_ t oo -. -c- o0- 'IC a s - 0 N-l0%Owo m - 0 0o oc-C 0o c ON - W00- COCI,cm -_U,O tMcc-c 0 __o_ at -NNd - cc-t-_-r o --U,IN_ t N a '0 Ic-re _- Na'Oo Un 0oo0 ONCs u,cN-N OO 4n N o0 ,_ ooN 0n 0%- tn -4---- ----cN-- NC Nc-i - c-c- -- ----c-iNCS N- .-c---ic -- _ _4 _4 _4 _4 ___ N N U, 0% 0 '0U to Cd ~~~~>1 0 CE, http://jmg.bmj.com/ jo '0o.~~~~~~~1.0I0 o 0 4 0 N o '010 C)Cu 0 o -. X 0 co 0.r 0 ) Co Goc .0 .>.>. .0e C)'1 on September 28, 2021 by guest. Protected copyright. o >.I4 O4D, ^ Tu Cu~ Co.0 3~~~~ 00.J c C). 0% C u .0CC' C00)(0 co I.,- I-c 0-0 C) "O .c !CUoo d)uC- Cu44 .t0 U P. UUU-U P-, UlUPU U P- U UU UQUU U - ,UP-,UU-,U ,U-UUU UUUU UUUUu.- C4 °c C, N 0 '- P,(N4C:- Ocu 0 P., a4 5 4" .Q .>wS:~ o -u ux<°>nEoiH>e=:8W 03 F- -m~- p.4 < < HH<' k CI, < p4 0' Cc 0 Cc - c-CP- -4 '''''Im..~~~~~~~~~~~~~~~~~~~~~~~~~. "(Aw-Aac-I r F r Xb C) c-i w £) 04c-- ( <p40<OUxOP4<Z c-i 4 t 0 C . c - - c-Ic-"C- .- in .. oNenen~~0.A ~~~~~~~~~~C4tnC)wU,000 c- ennc c- c- --- c-I %6 %611q (lei C . - - A N NN N -c -i cc-c 0.0'e- ,IIE Ue tc c- (4 (1 (4 eq - C4 Ns Cs N N _.0'_._'0'0'0' " "e a, t- N 0000000000000% 0 cc- - -e - c c-I U cc- cc- . ..~C~ t U,n U CO A gene map of congenital malformations 509 - P-4~~ 0 0 U _< C: a 0 o f. e%. -xr0t ci J Med Genet: first published as 10.1136/jmg.31.7.507 on 1 July 1994. Downloaded from ci CA Q C , rU . E EUUco ~~~ ~~~00 0 co cn 3 04 .0 4 -o a & 0 C~ C0-'IO 7 0 0 cocu g ; c, 't co L;4 m < ci V~ *.* t - LCUX $U ^X -,Ua 4z4VQ 0000- 0 0000-00 0 000000000 000 tn00000- 0000 0 000 D - 0 o -N0 '4' 't N-0 U) N0U- UtNci e)[-N0 ~0 00ulf0 tn0 0Nt Lr)0 " 1" a- N e- a 0- 0 Ci d 00-Nt- - - 0cN e- M0 - 000N000000~ci00000M 0 ON-t o " U)M ~ x 0o 1-. 2 Me- -d C9 m O xD t m \ aD o -o --N000 0 O a tNU') 0 ciair ciacia', eNc'0 - M c-QO -000000 0 - 00 0 W)00 o o ci0 0 04m 0 C m m t ci 0,1 o -teM N - - - - -- cicic---- N- ci-- cmmemem tmcemt 0 http://jmg.bmj.com/ 0. 0 0 03 0 cl 0 0 -o 0 .- 0 7- U0 co U 0 00 E on September 28, 2021 by guest. Protected copyright. CCEU > o 'I0 C10 0 us0 Uo*0 ac c, a on, 0~1 e 03 UUC-, > 0. - 0cn~~~~~~ 0 0 U.t~ - Irsl .- a) - 0Z 0 Uc ( UU 0 0IS-zr.--ZU~DM 04:W~ /ih7 6= . 3 ) -0 Im UUUO .UUUU .UU Un.be 0 0~ 0 Up.-UUU U P.-UUUp.Up.- U USo4p.Up.-UUU o.UU PU)UUP.- P.UUU t3 ci cn m:~~~c t 2co2 x~- z t- - 0<^ 0.
Load more

Recommended publications
  • Next Generation Sequencing Panels for Disorders of Sex Development
    Next Generation Sequencing Panels for Disorders of Sex Development Disorders of Sex Development – Overview Disorders of sex development (DSDs) occur when sex development does not follow the course of typical male or female patterning. Types of DSDs include congenital development of ambiguous genitalia, disjunction between the internal and external sex anatomy, incomplete development of the sex anatomy, and abnormalities of the development of gonads (such as ovotestes or streak ovaries) (1). Sex chromosome anomalies including Turner syndrome and Klinefelter syndrome as well as sex chromosome mosaicism are also considered to be DSDs. DSDs can be caused by a wide range of genetic abnormalities (2). Determining the etiology of a patient’s DSD can assist in deciding gender assignment, provide recurrence risk information for future pregnancies, and can identify potential health problems such as adrenal crisis or gonadoblastoma (1, 3). Sex chromosome aneuploidy and copy number variation are common genetic causes of DSDs. For this reason, chromosome analysis and/or microarray analysis typically should be the first genetic analysis in the case of a patient with ambiguous genitalia or other suspected disorder of sex development. Identifying whether a patient has a 46,XY or 46,XX karyotype can also be helpful in determining appropriate additional genetic testing. Abnormal/Ambiguous Genitalia Panel Our Abnormal/Ambiguous Genitalia Panel includes mutation analysis of 72 genes associated with both syndromic and non-syndromic DSDs. This comprehensive panel evaluates a broad range of genetic causes of ambiguous or abnormal genitalia, including conditions in which abnormal genitalia are the primary physical finding as well as syndromic conditions that involve abnormal genitalia in addition to other congenital anomalies.
    [Show full text]
  • The National Economic Burden of Rare Disease Study February 2021
    Acknowledgements This study was sponsored by the EveryLife Foundation for Rare Diseases and made possible through the collaborative efforts of the national rare disease community and key stakeholders. The EveryLife Foundation thanks all those who shared their expertise and insights to provide invaluable input to the study including: the Lewin Group, the EveryLife Community Congress membership, the Technical Advisory Group for this study, leadership from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), the Undiagnosed Diseases Network (UDN), the Little Hercules Foundation, the Rare Disease Legislative Advocates (RDLA) Advisory Committee, SmithSolve, and our study funders. Most especially, we thank the members of our rare disease patient and caregiver community who participated in this effort and have helped to transform their lived experience into quantifiable data. LEWIN GROUP PROJECT STAFF Grace Yang, MPA, MA, Vice President Inna Cintina, PhD, Senior Consultant Matt Zhou, BS, Research Consultant Daniel Emont, MPH, Research Consultant Janice Lin, BS, Consultant Samuel Kallman, BA, BS, Research Consultant EVERYLIFE FOUNDATION PROJECT STAFF Annie Kennedy, BS, Chief of Policy and Advocacy Julia Jenkins, BA, Executive Director Jamie Sullivan, MPH, Director of Policy TECHNICAL ADVISORY GROUP Annie Kennedy, BS, Chief of Policy & Advocacy, EveryLife Foundation for Rare Diseases Anne Pariser, MD, Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health Elisabeth M. Oehrlein, PhD, MS, Senior Director, Research and Programs, National Health Council Christina Hartman, Senior Director of Advocacy, The Assistance Fund Kathleen Stratton, National Academies of Science, Engineering and Medicine (NASEM) Steve Silvestri, Director, Government Affairs, Neurocrine Biosciences Inc.
    [Show full text]
  • Joint Hypermobility Syndromes
    10/17/2017 Hereditary Disorders of Connective Tissue: Overview CLAIR A. FRANCOMANO, M.D. HARVEY INSTITUTE FOR HUMAN GENETICS BALTIMORE, MD Disclosures I have no conflicts to disclose 1 10/17/2017 Joint Hypermobility Seen in over 140 clinical syndromes listed in Online Mendelian Inheritance in Man (OMIM) Congenital anomaly syndromes Short stature syndromes Hereditary disorders of connective tissue Connective Tissue Supports and Protects Bones Collagen Fibers Cartilage Elastic Fibers Tendons Mucopolysaccharides Ligaments 2 10/17/2017 Fibrillar Collagens Major structural components of the extracellular matrix Include collagen types I, II, III, V, IX, and XI Trimeric molecules (three chains) May be made up of three identical or genetically distinct chains, called alpha chains Fibrillar Collagens Biochemical Society Transactions (1999) , - - www.biochemsoctrans.org 3 10/17/2017 Hereditary Disorders of Connective Tissue Marfan syndrome Loeys-Dietz syndrome Stickler syndrome Osteogenesis Imperfecta Ehlers-Danlos syndromes Marfan Syndrome Aneurysmal dilation of the ascending aorta Dislocation of the ocular lenses Tall stature Scoliosis Pectus deformity Arachnodactyly (long, narrow fingers and toes) Dolicostenomelia (tall, thin body habitus) Caused by mutations in Fibrillin-1 4 10/17/2017 Marfan Syndrome Loeys-Dietz Syndrome Aortic dilation with dissection Tortuous blood vessels Craniofacial features Hypertelorism Malar hypoplasia Cleft palate or bifid uvula Caused by mutations in TGFBR1 and TGFBR2 as well as
    [Show full text]
  • MR Imaging of Kallmann Syndrome, a Genetic Disorder of Neuronal Migration Affecting the Olfactory and Genital Systems
    MR Imaging of Kallmann Syndrome, a Genetic Disorder of Neuronal Migration Affecting the Olfactory and Genital Systems 1 2 2 3 4 Charles L. Truwit, ' A. James Barkovich, Melvin M. Grumbach, and John J. Martini PURPOSE: We report the MR findings in nine patients with clinical and laboratory evidence of Kallmann syndrome (KS), a genetic disorder of olfactory and gonadal development. In patients with KS, cells that normally express luteinizing hormone-releasing hormone fail to migrate from the medial olfactory placode along the terminalis nerves into the forebrain. In addition, failed neuronal migration from the lateral olfactory placode along the olfactory fila to the forebrain results in aplasia or hypoplasia of the olfactory bulbs and tracts. Patients with KS, therefore, suffer both reproductive and olfactory dysfunction. METHODS: Nine patients with KS underwent direct coronal MR of their olfactory regions in order to assess the olfactory sulci, bulbs, and tracts. A lOth patient had MR findings of KS, although the diagnosis is not yet confirmed by laboratory tests. RESULTS: Abnormalities of the olfactory system were identified in all patients. In particular, the anterior portions of the olfactory sulci were uniformly hypoplastic. The olfactory bulbs and tracts appeared hypoplastic or aplastic in all patients in whom the bulb/ tract region was satisfactorily imaged. In two (possibly three) patients, prominent soft tissue in the region of the bulbs suggests radiographic evidence of neurons that have been arrested before migration. CONCLUSIONS: Previous investigators of patients with KS used axial MR images to demonstrate hypoplasia of the olfactory sulci but offered no assessment of the olfactory bulbs.
    [Show full text]
  • The Genetic Basis for Skeletal Diseases
    insight review articles The genetic basis for skeletal diseases Elazar Zelzer & Bjorn R. Olsen Harvard Medical School, Department of Cell Biology, 240 Longwood Avenue, Boston, Massachusetts 02115, USA (e-mail: [email protected]) We walk, run, work and play, paying little attention to our bones, their joints and their muscle connections, because the system works. Evolution has refined robust genetic mechanisms for skeletal development and growth that are able to direct the formation of a complex, yet wonderfully adaptable organ system. How is it done? Recent studies of rare genetic diseases have identified many of the critical transcription factors and signalling pathways specifying the normal development of bones, confirming the wisdom of William Harvey when he said: “nature is nowhere accustomed more openly to display her secret mysteries than in cases where she shows traces of her workings apart from the beaten path”. enetic studies of diseases that affect skeletal differentiation to cartilage cells (chondrocytes) or bone cells development and growth are providing (osteoblasts) within the condensations. Subsequent growth invaluable insights into the roles not only of during the organogenesis phase generates cartilage models individual genes, but also of entire (anlagen) of future bones (as in limb bones) or membranous developmental pathways. Different mutations bones (as in the cranial vault) (Fig. 1). The cartilage anlagen Gin the same gene may result in a range of abnormalities, are replaced by bone and marrow in a process called endo- and disease ‘families’ are frequently caused by mutations in chondral ossification. Finally, a process of growth and components of the same pathway.
    [Show full text]
  • Identi Cation of Three Novel Homozygous Variants in COL9A3
    Identication of three novel homozygous variants in COL9A3 causing autosomal-recessive Stickler Syndrome Aboulfazl Rad University of Tübingen: Eberhard Karls Universitat Tubingen Maryam Naja Universitätsklinikum Freiburg: Universitatsklinikum Freiburg Fatemeh Suri Shahid Beheshti University Soheila Abedini Mashhad University of Medical Sciences Stephen Loum Eberhard Karls Universitat Tubingen Ehsan Ghayoor Karimiani Mashhad University of Medical Sciences Narsis Daftarian Shahid Beheshti University David Murphy UCL: University College London Mohammad Doosti Mashhad University of Medical Sciences Afrooz Moghaddasi Shahid Beheshti University Hamid Ahmadieh Shahid Beheshti University Hamideh Sabbaghi Shahid Beheshti University Mohsen Rajati Mashhad University of Medical Sciences Ghaem Hospital Narges Hashemi Mashhad University of Medical Sciences Barbara Vona Eberhard Karls Universitat Tubingen Miriam Schmidts ( [email protected] ) Universitatsklinikum Freiburg https://orcid.org/0000-0002-1714-6749 Research Article Keywords: autosomal recessive Stickler syndrome, COL9A3, collagen, hearing loss, retinal detachment Posted Date: May 17th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-526117/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/10 Abstract Background: Stickler syndrome (STL) is a rare, clinically and molecularly heterogeneous connective tissue disorder. Pathogenic variants occurring in a variety of genes cause STL, mainly inherited in an autosomal
    [Show full text]
  • Supporting Information
    Supporting Information Torkamani et al. 10.1073/pnas.0802403105 Materials and Methods kinase sequences used to generate conserved motifs, as in Kannan Kinase Identifiers. Kinase protein and DNA reference sequences et al. (3), the Gibbs motif sampling method identifies characteristic were obtained from Kinbase. These reference sequences were motifs for each individual subdomain of the kinase catalytic core, used as the basis to assign various gene identifiers (including which are then used to generate high confidence motif-based Ensembl gene IDs, HGNC gene symbols, and Entrez gene IDs) Markov chain Monte Carlo multiple alignments based upon these to every known human protein kinase. Ultimately, only eukary- motifs (4). These subdomains compromise the core structural otic protein kinases, that is, all human protein kinases except components of the protein kinase catalytic core. Intervening re- those belonging to the atypical protein kinase family, were gions between these subdomains were not aligned. considered in this study. The various gene identifiers were assigned as follows: Ensembl Mapping to Multiple Alignments and Generation of Logo Figures. A Gene ID’s were determined for each protein kinase by BLAST- nonredundant set of SNPs was generated to be mapped to the ing the reference Kinbase protein sequence against the Ensembl alignment computationally. That is, if multiple disease or com- ࿝ database (www.ensembl.org/Homo sapiens/blastview). The En- mon SNPs have been observed at a particular position within a sembl Gene ID of the top hit was assigned to the protein kinase. particular protein kinase, it is only considered once in our The Ensembl Gene ID was then used as a query in Biomart analysis.
    [Show full text]
  • Repercussions of Inborn Errors of Immunity on Growth☆ Jornal De Pediatria, Vol
    Jornal de Pediatria ISSN: 0021-7557 ISSN: 1678-4782 Sociedade Brasileira de Pediatria Goudouris, Ekaterini Simões; Segundo, Gesmar Rodrigues Silva; Poli, Cecilia Repercussions of inborn errors of immunity on growth☆ Jornal de Pediatria, vol. 95, no. 1, Suppl., 2019, pp. S49-S58 Sociedade Brasileira de Pediatria DOI: https://doi.org/10.1016/j.jped.2018.11.006 Available in: https://www.redalyc.org/articulo.oa?id=399759353007 How to cite Complete issue Scientific Information System Redalyc More information about this article Network of Scientific Journals from Latin America and the Caribbean, Spain and Journal's webpage in redalyc.org Portugal Project academic non-profit, developed under the open access initiative J Pediatr (Rio J). 2019;95(S1):S49---S58 www.jped.com.br REVIEW ARTICLE ଝ Repercussions of inborn errors of immunity on growth a,b,∗ c,d e Ekaterini Simões Goudouris , Gesmar Rodrigues Silva Segundo , Cecilia Poli a Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Departamento de Pediatria, Rio de Janeiro, RJ, Brazil b Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Curso de Especializac¸ão em Alergia e Imunologia Clínica, Rio de Janeiro, RJ, Brazil c Universidade Federal de Uberlândia (UFU), Faculdade de Medicina, Departamento de Pediatria, Uberlândia, MG, Brazil d Universidade Federal de Uberlândia (UFU), Hospital das Clínicas, Programa de Residência Médica em Alergia e Imunologia Pediátrica, Uberlândia, MG, Brazil e Universidad del Desarrollo,
    [Show full text]
  • A Study of the Clinical and Radiological Features in a Cohort of 93 Patients with a COL2A1 Mutation Causing Spondyloepiphyseal D
    RESEARCH ARTICLE A Study of the Clinical and Radiological Features in a Cohort of 93 Patients with a COL2A1 Mutation Causing Spondyloepiphyseal Dysplasia Congenita or a Related Phenotype Paulien A. Terhal,1* Rutger Jan A. J. Nievelstein,2 Eva J. J. Verver,3 Vedat Topsakal,3 Paula van Dommelen,4 Kristien Hoornaert,5 Martine Le Merrer,6 Andreas Zankl,7 Marleen E. H. Simon,8 Sarah F. Smithson,9 Carlo Marcelis,10 Bronwyn Kerr,11 Jill Clayton-Smith,11 Esther Kinning,12 Sahar Mansour,13 Frances Elmslie,13 Linda Goodwin,14 Annemarie H. van der Hout,15 Hermine E. Veenstra-Knol,15 Johanna C. Herkert,15 Allan M. Lund,16 Raoul C. M. Hennekam,17 Andre´ Me´garbane´,18 Melissa M. Lees,19 Louise C. Wilson,19 Alison Male,19 Jane Hurst,19,20 Yasemin Alanay,21 Go¨ran Annere´n,22 Regina C. Betz,23 Ernie M. H. F. Bongers,10 Valerie Cormier-Daire,6 Anne Dieux,24 Albert David,25 Mariet W. Elting,26 Jenneke van den Ende,27 Andrew Green,28 Johanna M. van Hagen,26 Niels Thomas Hertel,29 Muriel Holder-Espinasse,24,30 Nicolette den Hollander,31 Tessa Homfray, Hanne D. Hove,32 Susan Price,20 Annick Raas-Rothschild,33 Marianne Rohrbach,34 Barbara Schroeter,35 Mohnish Suri,36 Elizabeth M. Thompson,37 Edward S. Tobias,38 Annick Toutain,39 Maaike Vreeburg,40 Emma Wakeling,41 Nine V. Knoers,1 Paul Coucke,42,43 and Geert R. Mortier27,43 1Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands 2Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands 3Department of Otorhinolaryngology and Head and Neck Surgery,
    [Show full text]
  • Loss-Of-Function Mutation in the Prokineticin 2 Gene Causes
    Loss-of-function mutation in the prokineticin 2 gene SEE COMMENTARY causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism Nelly Pitteloud*†, Chengkang Zhang‡, Duarte Pignatelli§, Jia-Da Li‡, Taneli Raivio*, Lindsay W. Cole*, Lacey Plummer*, Elka E. Jacobson-Dickman*, Pamela L. Mellon¶, Qun-Yong Zhou‡, and William F. Crowley, Jr.* *Reproductive Endocrine Unit, Department of Medicine and Harvard Reproductive Endocrine Science Centers, Massachusetts General Hospital, Boston, MA 02114; ‡Department of Pharmacology, University of California, Irvine, CA 92697; §Department of Endocrinology, Laboratory of Cellular and Molecular Biology, Institute of Molecular Pathology and Immunology, University of Porto, San Joa˜o Hospital, 4200-465 Porto, Portugal; and ¶Departments of Reproductive Medicine and Neurosciences, University of California at San Diego, La Jolla, CA 92093 Communicated by Patricia K. Donahoe, Massachusetts General Hospital, Boston, MA, August 14, 2007 (received for review May 8, 2007) Gonadotropin-releasing hormone (GnRH) deficiency in the human associated with KS, although no functional data on the mutant presents either as normosmic idiopathic hypogonadotropic hypo- proteins were provided (17). Herein, we demonstrate that homozy- gonadism (nIHH) or with anosmia [Kallmann syndrome (KS)]. To gous loss-of-function mutations in the PROK2 gene cause IHH in date, several loci have been identified to cause these disorders, but mice and humans. only 30% of cases exhibit mutations in known genes. Recently, murine studies have demonstrated a critical role of the prokineticin Results pathway in olfactory bulb morphogenesis and GnRH secretion. Molecular Analysis of PROK2 Gene. A homozygous single base pair Therefore, we hypothesize that mutations in prokineticin 2 deletion in exon 2 of the PROK2 gene (c.[163delA]ϩ [163delA]) (PROK2) underlie some cases of KS in humans and that animals was identified in the proband, in his brother with KS, and in his deficient in Prok2 would be hypogonadotropic.
    [Show full text]
  • Kallmann Syndrome
    Kallmann syndrome Author: DoctorJean-Pierre Hardelin1 Creation date: July 1997 Updates: May 2002 December 2003 February 2005 Scientific editor: Professor Philippe Bouchard 1 Unité de Génétique des Déficits Sensoriels (INSERM U587), Institut Pasteur, 25 rue du Dr Roux, 75724 Paris cedex 15, France. [email protected] Abstract Keywords Disease name and synonyms Excluded diseases Diagnostic criteria / Definition Differential diagnosis Incidence Clinical description Management including treatment Etiology Diagnostic methods Genetic counseling Prenatal diagnosis Unresolved questions and comments References Abstract Kallmann syndrome combines hypogonadotropic hypogonadism due to GnRH deficiency, with anosmia or hyposmia. Magnetic resonance imaging (MRI) shows hypoplasia or aplasia of the olfactory bulbs. The incidence is estimated at 1 case in 10,000 males and 1 case in 50,000 females. The main clinical features consist of the association of micropenis and cryptorchidism in young boys, the absence of spontaneous puberty, a partial or total loss of the sense of smell (anosmia). Other possible signs include mirror movements of the upper limbs (synkinesis), unilateral or bilateral renal aplasia, cleft lip/palate, dental agenesis, arched feet, deafness. Diagnostic methods consist of hormones evaluation (GnRH stimulation test) as well as qualitative and quantitative olfactometric evaluation. Hormonal replacement is used to induce puberty, and later, fertility. Kallmann syndrome is due to an impaired embryonic development of the olfactory system and the GnRH-synthesizing neurons. Sporadic cases have been predominantly reported. Three modes of inheritance have been described in familial forms: X-linked recessive, autosomal dominant, or more rarely autosomal recessive. To date, only two of the genes responsible for this genetically heterogeneous disease have been identified: KAL-1, responsible for the X-linked form and FGFR1, involved in the autosomal dominant form (KAL-2).
    [Show full text]
  • Mutations Within Or Upstream of the Basic Helixð Loopð Helix Domain of the TWIST Gene Are Specific to Saethre-Chotzen Syndrome
    European Journal of Human Genetics (1999) 7, 27–33 © 1999 Stockton Press All rights reserved 1018–4813/99 $12.00 t http://www.stockton-press.co.uk/ejhg ARTICLES Mutations within or upstream of the basic helix–loop–helix domain of the TWIST gene are specific to Saethre-Chotzen syndrome Vincent El Ghouzzi, Elisabeth Lajeunie, Martine Le Merrer, Val´erie Cormier-Daire, Dominique Renier, Arnold Munnich and Jacky Bonaventure Unit´e de Recherches sur les Handicaps G´en´etiques de l’Enfant, Institut Necker, Paris, France Saethre-Chotzen syndrome (ACS III) is an autosomal dominant craniosynostosis syndrome recently ascribed to mutations in the TWIST gene, a basic helix–loop–helix (b-HLH) transcription factor regulating head mesenchyme cell development during cranial neural tube formation in mouse. Studying a series of 22 unrelated ACS III patients, we have found TWIST mutations in 16/22 cases. Interestingly, these mutations consistently involved the b-HLH domain of the protein. Indeed, mutant genotypes included frameshift deletions/insertions, nonsense and missense mutations, either truncating or disrupting the b-HLH motif of the protein. This observation gives additional support to the view that most ACS III cases result from loss-of-function mutations at the TWIST locus. The P250R recurrent FGFR 3 mutation was found in 2/22 cases presenting mild clinical manifestations of the disease but 4/22 cases failed to harbour TWIST or FGFR 3 mutations. Clinical re-examination of patients carrying TWIST mutations failed to reveal correlations between the mutant genotype and severity of the phenotype. Finally, since no TWIST mutations were detected in 40 cases of isolated coronal craniosynostosis, the present study suggests that TWIST mutations are specific to Saethre- Chotzen syndrome.
    [Show full text]